Dr. Temi Folaranmi
Vice President & Therapeutic Area Lead for Vaccines,
Medical and Clinical Affairs
GlaxoSmithKline(GSK)
Dr Temi Folaranmi is an accomplished global pharma executive and currently the Vice President and Therapeutic Area Lead for Vaccines Medical and Clinical Affairs at GlaxoSmithKline (GSK) in the United States. In this role, he provides strategic leadership to a multidisciplinary team of physicians, pharmacists, epidemiologists, and health outcome scientists, working collaboratively with various stakeholders to advance scientific knowledge and optimize the utilization of vaccines for disease prevention. As the senior vaccines physician for GSK in the U.S., Temi also serves as a scientific spokesperson for GSK Vaccines when required.
Temi earned his medical degree (MD) from Obafemi Awolowo University in Nigeria, followed by a Master of Public Health (MPH) from Harvard University, USA, and a Master of Public Policy (MPP) from the University of Oxford, UK. He is an alumnus of the CDC’s Epidemic Intelligence Service Fellowship, the Advanced Course of Vaccinology (ADVAC) in Annecy, France, Jeanne Sauvé Public Leaders Fellowship at McGill University, Canada and the McKinsey Black Executive Leadership Program.
